Ep199: Martin Burke on Making Small Molecule Medicines for the AI Era
Apr 21, 2026 - 01:10:08
Radio and PodcastLive Radio & PodcastsKen Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases is an episode from The Long Run with Luke Timmerman by The Long Run with Luke Timmerman. Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engagi...
This episode belongs to The Long Run with Luke Timmerman.
Use the player on this page to stream the episode online.
Published Mar 3, 2026, 01:05:45 long, audio available.
Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
You can listen to Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases online on Radio and Podcast. Open the player on this page to stream the available audio.
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases is an episode from The Long Run with Luke Timmerman by The Long Run with Luke Timmerman.
This episode is 01:05:45 long.
This episode was published on Mar 3, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Long Run with Luke Timmerman when more episodes are available from the podcast feed.
You can listen to Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases on this page when the episode audio is available from the podcast feed.
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases is from The Long Run with Luke Timmerman by The Long Run with Luke Timmerman.
Published Mar 3, 2026 and 01:05:45 long